Does Rallies show Form 4 insider transactions for ALHC?

Yes. Rallies tracks ALHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ALHC research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ALHC. It does not provide personalized investment advice.

ALHC (Alignment Healthcare, Inc. Common Stock) Stock Analysis - Insider Trades

Alignment Healthcare, Inc. Common Stock (ALHC) is a publicly traded Healthcare sector company. As of May 21, 2026, ALHC trades at $16.58 with a market cap of $3.37B and a P/E ratio of 0.00. ALHC moved +1.80% today. Year to date, ALHC is -20.67%; over the trailing twelve months it is +6.25%. Its 52-week range spans $9.15 to $23.87. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces ALHC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ALHC stock inside the company?

Recent ALHC insider activity includes KAO JOHN E sold 280.89K, KAO JOHN E sold 17.11K, Maroney Dawn Christine sold 30.00K, KAO JOHN E sold 82.30K, and KAO JOHN E sold 201.90K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ALHC Key Metrics

Key financial metrics for ALHC
Metric	Value
Price	$16.58
Market Cap	$3.37B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$23.87
52-Week Low	$9.15
Volume	562
Avg Volume	0
Revenue (TTM)	$3.95B
Net Income	$-978.00K
Gross Margin	0.00%

Recent ALHC Insider Trades

KAO JOHN E sold 280.89K (~$4.73M) on May 11, 2026.
KAO JOHN E sold 17.11K (~$299.97K) on May 11, 2026.
Maroney Dawn Christine sold 30.00K (~$626.20K) on Apr 15, 2026.
KAO JOHN E sold 82.30K (~$1.71M) on Apr 13, 2026.
KAO JOHN E sold 201.90K (~$4.16M) on Apr 10, 2026.

Latest ALHC News

Alignment Health Plan Earns 2026 Excellence Award, In Top 1.6% of MAPD Plans — May 14, 2026
Alignment Healthcare Elevates CEO to Chairman Role and Adds Three Senior Executives — May 12, 2026
Alignment Healthcare Raises 2026 Guidance After 33% Q1 Revenue Gain — May 1, 2026
Analysts Forecast Q1 Revenue of $1.22B, See 15.7% Upside on Alignment Healthcare — Apr 29, 2026
Insiders Sell 95,639 Shares for $1.7M; Hudson Bay Takes 262,500-Share Stake — Mar 22, 2026

ALHC Analyst Consensus

9 analysts cover ALHC: 0 strong buy, 7 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.

Common questions about ALHC

Who is trading ALHC stock inside the company?: Recent ALHC insider activity includes KAO JOHN E sold 280.89K, KAO JOHN E sold 17.11K, Maroney Dawn Christine sold 30.00K, KAO JOHN E sold 82.30K, and KAO JOHN E sold 201.90K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ALHC?: Yes. Rallies tracks ALHC insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ALHC research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ALHC. It does not provide personalized investment advice.